SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-023207
Filing Date
2022-11-08
Accepted
2022-11-08 16:08:45
Documents
61
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idya-20220930.htm   iXBRL 10-Q 3596316
2 EX-10.1 idya-ex10_1.htm EX-10.1 931796
3 EX-31.1 idya-ex31_1.htm EX-31.1 20354
4 EX-31.2 idya-ex31_2.htm EX-31.2 19898
5 EX-32.1 idya-ex32_1.htm EX-32.1 17182
  Complete submission text file 0000950170-22-023207.txt   10814439

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT idya-20220930_cal.xml EX-101.CAL 39027
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idya-20220930_def.xml EX-101.DEF 156463
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idya-20220930_pre.xml EX-101.PRE 282623
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idya-20220930_lab.xml EX-101.LAB 395874
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idya-20220930.xsd EX-101.SCH 44904
55 EXTRACTED XBRL INSTANCE DOCUMENT idya-20220930_htm.xml XML 1732334
Mailing Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-443-6209
IDEAYA Biosciences, Inc. (Filer) CIK: 0001676725 (see all company filings)

IRS No.: 474268251 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38915 | Film No.: 221368932
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences